51 – 60 of 698
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Why Hereditas leads hereditary cancer awareness now more than ever
- Contribution to journal › Debate/Note/Editorial
-
Mark
Understanding the characteristic behaviour of the wild-type and mutant structure of FLT3 protein by computational methods
- Contribution to journal › Article
-
Mark
Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
- Contribution to journal › Article
-
Mark
Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibroblasts with Tumor-Restraining Properties
- Contribution to journal › Article
-
Mark
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels
- Contribution to journal › Article
-
Mark
Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma
- Contribution to journal › Article
-
Mark
Proteomics discovery of MTDH and SND1 interaction vulnerabilities in ovarian cancer
- Contribution to journal › Article
-
Mark
Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma
(2025) In EMBO Molecular Medicine
- Contribution to journal › Article
-
Mark
Novel 1-(2-Aryl-2-adamantyl)piperazine Derivatives Exhibit In Vitro Anticancer Activity Across Various Human Cancer Cell Lines, with Selective Efficacy Against Melanoma
- Contribution to journal › Article
-
Mark
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK : a retrospective analysis
- Contribution to journal › Article
